Health knowledge made personal
Join this community!
› Share page:
Search posts:

Rethinking Alzheimer’s research, beyond amyloid deposition, via new funding models

Posted Jul 03 2014 6:01pm

Alzheimer_Word_cloud_conceptHow a new approach to funding Alzheimer’s research could pay off (MIT News):

“More than 5 million Americans suffer from Alzheimer’s disease, the affliction that erodes memory and other mental capacities, but no drugs targeting the disease have been approved by the U.S. Food and Drug Administration since 2003…Lo and three co-authors propose creating a public-private partnership that would fund research for a diverse array of drug-discovery projects simultaneously. Such an approach would increase the chances of a therapeutic breakthrough, they say, and the inclusion of public funding would help mitigate the risks and costs of Alzheimer’s research for the private sector.

The main hypothesis on the cause of Alzheimer’s involves amyloid deposition, the buildup of plaques in the brain that impair neurological function; most biomedical efforts to tackle the disease have focused on this issue. For the study, Ho and Kosik, leading experts in Alzheimer’s research, compiled a list of 64 conceivable approaches to drug discovery, addressing a range of biological mechanisms that may be involved in the disease.”

Study: Parallel Discovery of Alzheimer’s Therapeutics (Science Translational Medicine)

Post a comment
Write a comment:

Related Searches